Zacks Research Analysts Increase Earnings Estimates for BAX

Baxter International Inc. (NYSE:BAX) – Stock analysts at Zacks Research boosted their Q2 2027 earnings estimates for Baxter International in a research report issued to clients and investors on Monday, September 28th. Zacks Research analyst Team now forecasts that the medical instruments supplier will post earnings of $0.51 per share for the quarter, up from their previous estimate of $0.50. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share.

Several other equities research analysts also recently commented on the company. The Goldman Sachs Group lifted their price objective on Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Citigroup raised shares of Baxter International from a “sell” rating to a “neutral” rating and raised their price target for the company from $17.00 to $28.00 in a report on Friday, July 31st. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, July 31st. Finally, Stifel Nicolaus increased their price objective on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $22.45.

Baxter International Stock Up 0.0%

Baxter International stock opened at $23.50 on Tuesday. Baxter International has a 12 month low of $15.73 and a 12 month high of $30.00. The stock has a fifty day simple moving average of $25.22 and a two-hundred day simple moving average of $21.20. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The firm has a market cap of $12.15 billion, a price-to-earnings ratio of -11.35, a PEG ratio of 3.55 and a beta of 0.60.

Baxter International (NYSE:BAX) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.80 billion. During the same quarter in the prior year, the company posted $0.59 earnings per share. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Institutional Trading of Baxter International

Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in Baxter International in the second quarter worth approximately $1,744,874,000. Pzena Investment Management LLC purchased a new stake in shares of Baxter International in the 2nd quarter worth $1,392,098,000. Geode Capital Management LLC raised its holdings in Baxter International by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 13,510,205 shares of the medical instruments supplier’s stock worth $257,174,000 after purchasing an additional 972,891 shares during the period. Equity Investment Corp bought a new position in Baxter International in the 2nd quarter worth $146,815,000. Finally, Bank of America Corp DE purchased a new position in Baxter International during the second quarter valued at $132,993,000. 90.19% of the stock is currently owned by institutional investors.

Baxter International Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, August 28th. Baxter International’s dividend payout ratio is -1.93%.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.